Physician profile
Jonathan D Kaplan
NPI 1053491696
$55,857.15
in general payments reported to CMS, 2019-2025
11 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.72 · 2020: $22.11 · 2021: $28K · 2022: $47.59 · 2023: $757 · 2024: $666 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $3,870 · Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,250.00 |
| Travel and Lodging | $3,869.79 |
| Food and Beverage | $753.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vilex LLC | $27,830.05 | 2021 | |
| Treace Medical Concepts, INC. | $27,245.58 | 2023-2025 | |
| Amgen INC. | $236.87 | 2024-2025 | Krystexxa |
| Medshape, INC. | $149.68 | 2024 | Dynanail |
| Stryker Corporation | $141.70 | 2019-2025 | Flexband |
| Orthofix Medical, INC. | $86.94 | 2019-2024 | Physio-Stim |
| Smith+Nephew, INC. | $79.63 | 2019-2023 | Stravix Pl, Grafix Pl, Grafix |
| Paratek Pharmaceuticals, INC. | $37.48 | 2022-2024 | Nuzyra |
| Nevro Corp. | $23.86 | 2022 | |
| Melinta Therapeutics, LLC | $13.15 | 2019 | |
| Fidia Pharma USA INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.